Clinical trials
6 active studies led by Pulse Biosciences, Inc., of 17 in all
Source: ClinicalTrials.gov, Studies with Pulse Biosciences, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 2Markets in public records
- 0Regions & countries
- 6Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Pulse Biosciences, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Pulse Biosciences, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Stock listing
- NASDAQ: PLSE
- Type
- Medical devices
Source: SEC EDGAR, Company filings, CIK 1625101. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
US device clearances
7 510(k) clearances and PMA approvals since 2015
- Cellfx Percutaneous Electrode System (Sys3000); Cellfx Percutaneous Electrode, … K240782 · 5 Aug 2024
- Cellfx Percutaneous Electrode System (Sys3000) K233705 · 8 Mar 2024
- Cellfx System K213674 · 22 Sep 2022
- Cellfx System K222075 · 2 Sep 2022
- Cellfx® System K221671 · 1 Aug 2022
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
SEC filings
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1625101.
Trials over time
Studies Pulse Biosciences, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Pulse Biosciences, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Pulse Biosciences, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Pulse Biosciences, Inc. is in.
From our blog
Stories on the topics Pulse Biosciences, Inc. works in.
Omega-3: Heart, Brain and the Evidence Debate
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Ambulatory Surgery Centres: Same-Day Surgery Grows
More than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
Read
Angiography: Seeing Inside the Blood Vessels
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
ReadSearch all reports for Pulse Biosciences, Inc. All companies